Background As a major virus outbreak in the 21st century, the Coronavirus disease 2019 (COVID-19)
pandemic has led to unprecedented hazards to mental health globally. While …

In addition to being a public physical health emergency, Coronavirus disease 2019 (COVID-19)
affected global mental health, as evidenced by panic-buying worldwide as cases soared…

The Canadian Network for Mood and Anxiety Treatments ( CANMAT ) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Objective: To review extant literature implicating inflammation in the pathophysiology of
bipolar disorder. Furthermore, we review evidence regarding the anti-inflammatory actions of …

Atypical antipsychotics such as clozapine represent a significant improvement over typical
antipsychotics in the treatment of schizophrenia, particularly regarding extrapyramidal …

Background Few reports have aimed to describe the mediational effect of cognitive deficits
on functional outcomes in major depressive disorder (MDD), and relatively few interventions …

Mood disorders have been recognized by the World Health Organization (WHO) as the
leading cause of disability worldwide. Notwithstanding the established efficacy of conventional …

Importance COVID-19 is associated with clinically significant symptoms despite resolution
of the acute infection (ie, post-COVID-19 syndrome). Fatigue and cognitive impairment are …

Background Most adults with major depressive disorder (MDD) fail to achieve remission
with index pharmacological treatment. Moreover, at least half will not achieve and sustain …

This study aimed to assess and compare the immediate stress and psychological impact
experienced by people with and without psychiatric illnesses during the peak of 2019 …